These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 17576872)

  • 1. Assessment of functional capacity in clinical and research settings: a scientific statement from the American Heart Association Committee on Exercise, Rehabilitation, and Prevention of the Council on Clinical Cardiology and the Council on Cardiovascular Nursing.
    Arena R; Myers J; Williams MA; Gulati M; Kligfield P; Balady GJ; Collins E; Fletcher G; ;
    Circulation; 2007 Jul; 116(3):329-43. PubMed ID: 17576872
    [No Abstract]   [Full Text] [Related]  

  • 2. Physical activity and exercise recommendations for stroke survivors: an American Heart Association scientific statement from the Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention; the Council on Cardiovascular Nursing; the Council on Nutrition, Physical Activity, and Metabolism; and the Stroke Council.
    Gordon NF; Gulanick M; Costa F; Fletcher G; Franklin BA; Roth EJ; Shephard T;
    Stroke; 2004 May; 35(5):1230-40. PubMed ID: 15105522
    [No Abstract]   [Full Text] [Related]  

  • 3. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 6: Hypertension: A Scientific Statement from the American Heart Association and the American College of Cardiology.
    Black HR; Sica D; Ferdinand K; White WB;
    Circulation; 2015 Dec; 132(22):e298-302. PubMed ID: 26621647
    [No Abstract]   [Full Text] [Related]  

  • 4. Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation.
    Balady GJ; Williams MA; Ades PA; Bittner V; Comoss P; Foody JA; Franklin B; Sanderson B; Southard D; ; ; ;
    J Cardiopulm Rehabil Prev; 2007; 27(3):121-9. PubMed ID: 17558191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation.
    Balady GJ; Williams MA; Ades PA; Bittner V; Comoss P; Foody JM; Franklin B; Sanderson B; Southard D; ; ; ; ;
    Circulation; 2007 May; 115(20):2675-82. PubMed ID: 17513578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoting physical activity in children and youth: a leadership role for schools: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism (Physical Activity Committee) in collaboration with the Councils on Cardiovascular Disease in the Young and Cardiovascular Nursing.
    Pate RR; Davis MG; Robinson TN; Stone EJ; McKenzie TL; Young JC; ; ;
    Circulation; 2006 Sep; 114(11):1214-24. PubMed ID: 16908770
    [No Abstract]   [Full Text] [Related]  

  • 7. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Maron BJ; Levine BD; Washington RL; Baggish AL; Kovacs RJ; Maron MS;
    Circulation; 2015 Dec; 132(22):e267-72. PubMed ID: 26527714
    [No Abstract]   [Full Text] [Related]  

  • 8. Implementing American Heart Association pediatric and adult nutrition guidelines: a scientific statement from the American Heart Association Nutrition Committee of the Council on Nutrition, Physical Activity and Metabolism, Council on Cardiovascular Disease in the Young, Council on Arteriosclerosis, Thrombosis and Vascular Biology, Council on Cardiovascular Nursing, Council on Epidemiology and Prevention, and Council for High Blood Pressure Research.
    Gidding SS; Lichtenstein AH; Faith MS; Karpyn A; Mennella JA; Popkin B; Rowe J; Van Horn L; Whitsel L
    Circulation; 2009 Mar; 119(8):1161-75. PubMed ID: 19255356
    [No Abstract]   [Full Text] [Related]  

  • 9. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 8: Coronary Artery Disease: A Scientific Statement from the American Heart Association and American College of Cardiology.
    Thompson PD; Myerburg RJ; Levine BD; Udelson JE; Kovacs RJ
    J Am Coll Cardiol; 2015 Dec; 66(21):2406-2411. PubMed ID: 26542666
    [No Abstract]   [Full Text] [Related]  

  • 10. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Ackerman MJ; Zipes DP; Kovacs RJ; Maron BJ;
    Circulation; 2015 Dec; 132(22):e326-9. PubMed ID: 26527716
    [No Abstract]   [Full Text] [Related]  

  • 11. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 5: Valvular Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Bonow RO; Nishimura RA; Thompson PD; Udelson JE;
    Circulation; 2015 Dec; 132(22):e292-7. PubMed ID: 26621646
    [No Abstract]   [Full Text] [Related]  

  • 12. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association.
    Lichtman JH; Bigger JT; Blumenthal JA; Frasure-Smith N; Kaufmann PG; Lespérance F; Mark DB; Sheps DS; Taylor CB; Froelicher ES; ; ; ; ;
    Circulation; 2008 Oct; 118(17):1768-75. PubMed ID: 18824640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 1: Classification of Sports: Dynamic, Static, and Impact: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Levine BD; Baggish AL; Kovacs RJ; Link MS; Maron MS; Mitchell JH;
    Circulation; 2015 Dec; 132(22):e262-6. PubMed ID: 26621643
    [No Abstract]   [Full Text] [Related]  

  • 14. Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 8: Coronary Artery Disease: A Scientific Statement from the American Heart Association and American College of Cardiology.
    Thompson PD; Myerburg RJ; Levine BD; Udelson JE; Kovacs RJ;
    Circulation; 2015 Dec; 132(22):e310-4. PubMed ID: 26621649
    [No Abstract]   [Full Text] [Related]  

  • 15. AHA Science Advisory. Resistance exercise in individuals with and without cardiovascular disease: benefits, rationale, safety, and prescription: An advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association; Position paper endorsed by the American College of Sports Medicine.
    Pollock ML; Franklin BA; Balady GJ; Chaitman BL; Fleg JL; Fletcher B; Limacher M; Piña IL; Stein RA; Williams M; Bazzarre T
    Circulation; 2000 Feb; 101(7):828-33. PubMed ID: 10683360
    [No Abstract]   [Full Text] [Related]  

  • 16. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 4: Congenital Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Van Hare GF; Ackerman MJ; Evangelista JA; Kovacs RJ; Myerburg RJ; Shafer KM; Warnes CA; Washington RL;
    Circulation; 2015 Dec; 132(22):e281-91. PubMed ID: 26621645
    [No Abstract]   [Full Text] [Related]  

  • 17. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 14: Sickle Cell Trait: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Maron BJ; Harris KM; Thompson PD; Eichner ER; Steinberg MH;
    Circulation; 2015 Dec; 132(22):e343-5. PubMed ID: 26527715
    [No Abstract]   [Full Text] [Related]  

  • 18. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Zipes DP; Link MS; Ackerman MJ; Kovacs RJ; Myerburg RJ; Estes NA;
    Circulation; 2015 Dec; 132(22):e315-25. PubMed ID: 26621650
    [No Abstract]   [Full Text] [Related]  

  • 19. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 11: Drugs and Performance-Enhancing Substances: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Estes NA; Kovacs RJ; Baggish AL; Myerburg RJ;
    Circulation; 2015 Dec; 132(22):e330-3. PubMed ID: 26621651
    [No Abstract]   [Full Text] [Related]  

  • 20. Implications of Cardio-Respiratory Fitness on the Performance of Exercise Tests.
    Jelinek M; Hossack K
    Heart Lung Circ; 2019 Apr; 28(4):e64-e66. PubMed ID: 30269873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.